A missed opportunity for GS1 to explain why India’s barcoding programme is not a danger to society Avi Chaudhuri Sep 23, 2026 A recent essay in Express Pharma by Mr. S. Swaminathan, CEO of GS1 India, extolled the benefits of the QR barcoding programme and…
The myth of drug traceability in India EP News Bureau Sep 9, 2025 India launched a drug traceability programme more than a decade ago with the objective of stemming the flow of counterfeit…
A defining opportunity for clarity from GS1 Avi Chaudhuri, PhD May 14, 2025 Avi Chaudhuri, PhD - Founder, The Kulinda Consortium, presents a set of assertions made about counterfeit medicines problem along…
Sun Pharma must immediately declare a voluntary recall of Levipil 500 Avi Chaudhuri, PhD, Founder, The Kulinda Consortium Apr 28, 2025 Dr Avi Chaudhuri, expert on anti-counterfeiting has further analysed the recent counterfeiting case of Sun Pharma’s Levipil 500.…